Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services is poised for long-term growth, driven by a strong labor disruption market and a solid growth algorithm that supports mid-single-digit revenue growth and double-digit EBITDA growth. With a majority of revenue coming from the Nurse and Allied Solutions segment, improving segment performance and gross margin should drive strong financial results. The recent acquisitions of ESSENTIAL Leadership Assessment and Jaide Health demonstrate the company's focus on expanding its technology and workforce solutions. Additionally, AMN has a solid balance sheet with a target debt leverage of 2.0x or less, providing opportunities for strategic investments and future growth.

Bears say

AMN Healthcare Services is facing challenges including a decline in demand for staffing services, potentially due to industry consolidation and the loss of their largest customer, Kaiser Permanente. This has resulted in revenue contraction and a decrease in segment gross margins. Additionally, their VMS revenue has been declining, leading to a decrease in overall revenue for the company. However, as the post-COVID demand shock settles, the company's business may stabilize and return to mid-single digit growth, potentially driving double-digit earnings growth and making the stock a buy opportunity.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.